Nanomedicine/materdicine-enabled sonocatalytic therapy

Area of Science:

• Nanomedicine and Materidicine
• Biomedical Engineering
• Theranostics

Background:

• Ultrasound (US)-triggered sonocatalytic therapy offers a minimally invasive approach for diagnostics and therapeutics.
• Sonocatalytic therapy overcomes the penetration depth limitations inherent in phototherapeutic methods.
• Optimization of sonosensitizers and therapies is crucial for improving precision, intelligence, and efficiency.

Purpose of the Study:

• To provide a comprehensive review of nanomedicine/materidicine-enabled sonocatalytic therapy.
• To discuss the design, biological features, and sonocatalytic functions of nanomedicine/materidicine-based sonosensitizers.
• To explore synergistic therapeutic approaches and future perspectives in the field.

Main Methods:

• Review of current literature on nanomedicine and materidicine in sonocatalytic therapy.
• Analysis of design methodologies and biological characteristics of nanomedicine/materidicine-based sonosensitizers.
• Discussion of synergistic therapeutic strategies and their efficacy.

Main Results:

• Nanomedicine and materidicine significantly enhance the theranostic efficiency of sonocatalytic therapy.
• Understanding the structure-function-biological effect relationship of sonosensitizers is key.
• Synergistic therapies show promise for improved treatment outcomes.

Conclusions:

• Nanomedicine/materidicine-based sonocatalytic therapy presents a promising avenue for advanced disease treatment.
• Further research is needed to address challenges in precision, intelligence, and efficiency.
• Technological advancements and clinical translation are essential for realizing the full potential of this therapy.